Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype-Reference-Cited by-同舟云学术

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

Published:1999-07 Issue:28 Volume:18 Page:4144-4152
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Smith Justin S,Alderete Benjamin,Minn Yuriko,Borell Thomas J,Perry Arie,Mohapatra Gayatry,Hosek Sandra M,Kimmel David,O'Fallon Judith,Yates Allan,Feuerstein Burt G,Burger Peter C,Scheithauer Bernd W,Jenkins Robert B

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1202759.pdf

Reference45 articles.

1. Ashworth LK, Batzer MA, Brandriff B, Branscomb E, de Jong P, Garcia E, Garnes JA, Gordon LA, Lamerdin JE, Lennon G, Mohrenweiser H, Olsen AS, Slezak T and Carrano AV. . 1995 Nat. Genet. 11: 422–427.

2. Baer R. . 1993 Sem. Cancer Biol. 4: 341–347.

3. Bello MJ, Leone E, Vaquer J, De Campos JM, Kusak ME, Sarasa JL, Pestaña A and Rey JA. . 1995 Int. J. Cancer 64: 207–210.

4. Bello MJ, Vaquero J, De Campos JM, Kusak ME, Sarasa JL, Saez-Castresana J, Pestana A and Rey JA. . 1994 Int. J. Cancer 57: 172–175.

5. Cairncross JG and Macdonald DR. . 1988 Ann. Neurol. 23: 350–364.

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An atlas of causal and mechanistic drivers of interpatient heterogeneity in glioma;2024-04-07

2. A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas;Journal of Neuropathology & Experimental Neurology;2024-02-26

3. Expression of EMP 1, 2, and 3 in Adrenal Cortical Neoplasm and Pheochromocytoma;International Journal of Molecular Sciences;2023-08-21

4. The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma;Disease Markers;2023-01-17

5. Nanotechnology-based cancer chemoprevention in glioblastoma;Folia Neuropathologica;2023